University of Louisville, Kidney Disease Program
Welcome,         Profile    Billing    Logout  
 1 Trial 
3 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Ward, Richard
CRESCENDO, NCT06072131: To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL

Recruiting
3
504
Europe, US, RoW
Belinostat Injection, Beleodaq®, Pralatrexate Injection, Folotyn®, CHOP, Cyclophosphamide, Hydroxydaunorubicin (doxorubicin), Oncovin (vincristine), and Prednisone, COP, Cyclophosphamide, Oncovin (vincristine), and Prednisone
Acrotech Biopharma Inc.
Peripheral T Cell Lymphoma
07/30
11/30
NCT04198623: Efficacy of Montelukast in Reducing the Incidence and Severity of Monoclonal Antibodies Associated Infusion Reactions

Recruiting
2
80
US
Montelukast 10 Mg Oral Tablet, Singulair
University of California, San Francisco
Infusion Reaction, Monoclonal Antibody
05/24
05/24
NCT04405115: Improving Survivorship Care for Older Adults After Chemotherapy

Recruiting
N/A
70
US
Geriatric Assessment
University of California, San Francisco
Survivorship
05/25
05/25

Download Options